CellVec endeavour to optimise a balance between innovation, efficiency and safety, while ensuring compliance with current GMP regulatory standards.
CellVec’s state-of-the-art GMP manufacturing facility encompasses the process-driven design approach that it adopts for the manufacture of viral vectors for gene therapy and other cellular ATMPs.
In partnership with leading EPCMV service providers, our GMP facility was designed and built in accordance with a stringent tender, quality and GMP review process.
